SKU(재고 관리 코드):LAB780Hu81
FITC-Linked Polyclonal Antibody to Orosomucoid 2 (ORM2)
FITC-Linked Polyclonal Antibody to Orosomucoid 2 (ORM2)
Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.
Product No.
LAB780Hu81
Organism Species
Homo sapiens (Human).
Source
Antibody labeling
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
FITC
Original Antibody
n/a
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
500µg/mL
Organism Species More
n/a
Applications
WB; IHC; ICC; IF.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against ORM2. It has been selected for its ability to recognize ORM2 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Magazine |
Citations |
Clin Exp Nephrol |
Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome PubMed: 26351173 |
Free Patents online |
RHEUMATOID ARTHRITIS RELATED BIOMARKER 20170350884 |
Osteoarthritis and Cartilage |
Orosomucoid 2 serves for predicting but not for monitoring drug response in patients with knee osteoarthritis treated with chondroitin sulfate/glucosamine … 10.1016:j.joca.2018.02.412 |
Therapeutic Advances in Chronic Disease |
Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis |
Journal of Cosmetic Dermatology |
Evaluation of serum and urinary orsomucoid protein A in psoriatic patients and their relation to severity of disease 33905172 |
Catalog No. |
Related products for research use of Homo sapiens (Human) Organism species |
Applications (RESEARCH USE ONLY!) |
RPB780Hu01 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
CPB780Hu21 |
Immunogen; SDS-PAGE; WB. |
|
PAB780Hu01 |
WB; IHC; ICC; IP. |
|
LAB780Hu81 |
WB; IHC; ICC; IF. |
|
LAB780Hu71 |
WB; IHC; ICC. |
|
MAB780Hu22 |
WB,IHC |
|
MAB780Hu21 |
WB; IHC; ICC; IP. |
|
SEB780Hu |
Enzyme-linked immunosorbent assay for Antigen Detection. |
|
LMB780Hu |
Magnetic Luminex Assay for Antigen Detection. |